Atlas Trials

Fuzhou General Hospital

40 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fuzhou General Hospital

RecordFirmDate
SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer (NCT06772376)Fuzhou General Hospital2026-05-01
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis (NCT06772363)Fuzhou General Hospital2026-04-09
SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules (NCT06775587)Fuzhou General Hospital2026-04-08
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type (NCT06775002)Fuzhou General Hospital2026-04-05
SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer (NCT06775015)Fuzhou General Hospital2026-04-04
Therapy for Advanced NSCLC With EGFR 19delins Mutation (NCT07458919)Fuzhou General Hospital2026-03-30
Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC (NCT07093762)Fuzhou General Hospital2025-08-20
The Efficacy and Safety of Azovudine in the Treatment of COVID-19 (NCT05675761)Fuzhou General Hospital2023-01-04
Defining COVID-19 Infection Severity on Presentation to Hospital (NCT05677789)Fuzhou General Hospital2023-01-04
ctDNA as a Biomarker for Treatment in Advanced NSCLC (NCT05486988)Fuzhou General Hospital2022-07-31
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma (NCT05515315)Fuzhou General Hospital2022-05-31
Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia (NCT05203055)Fuzhou General Hospital2021-12-10
QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration (NCT06766565)Fuzhou General Hospital2021-12-08
Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery (NCT04741490)Fuzhou General Hospital2021-02-01
Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. (NCT04490421)Fuzhou General Hospital2020-08-01
Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 (NCT04371601)Fuzhou General Hospital2020-03-01
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer (NCT04088110)Fuzhou General Hospital2019-11-01
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC (NCT04015661)Fuzhou General Hospital2019-07-09
The Plasma Diafiltration Therapy of Hepatic Failure (NCT03560414)Fuzhou General Hospital2018-06-01
Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma (NCT03567135)Fuzhou General Hospital2017-10-01

Track Fuzhou General Hospital automatically

Every clearance here is in the API, with alerts when new ones post.